ERBB2 and non-small cell lung carcinoma: HER-2, a receptor tyrosine kinase found on the surface of normal epithelial cells, acts as a confirmed oncogenic driver mutation characterized by overexpression or mutation in NSCLC, affecting 1.5–3% of patients with a median age of 62 years.